Genome-wide linkage scan for factors of metabolic syndrome in a Chinese population

BMC Genetics

Volumn 11, Issue , 2010, Pages

  Tam, Claudia H T ^a   Lam, Vincent K L ^a   So, Wing Yee ^a   Ma, Ronald C W ^a   Chan, Juliana C N ^a   Ng, Maggie C Y ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; CHROMOSOME 1; CHROMOSOME 12; CHROMOSOME 13; CHROMOSOME 17; CHROMOSOME 2; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME 9; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FEMALE; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GLUCOSE BLOOD LEVEL; HONG KONG; HUMAN; HUMAN GENOME; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; ORAL GLUCOSE TOLERANCE TEST; POPULATION GENETICS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; ASIAN; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; QUANTITATIVE TRAIT;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LOD SCORE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; QUANTITATIVE TRAIT, HERITABLE; YOUNG ADULT;

EID: 77950381165     PISSN: None     EISSN: 14712156     Source Type: Journal    
DOI: 10.1186/1471-2156-11-14     Document Type: Article

References (52)

1. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37(12):1595-1607. 10.2337/diabetes.37.12.1595, 3056758.
2. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama 2001, 285(19):2486-2497. 10.1001/jama.285.19.2486, 11368702.
3. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004, 110(10):1245-1250. 10.1161/01.CIR.0000140677.20606.0E, 15326067.
4. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J. The metabolic syndrome and chronic kidney disease in U.S. adults. Annals of internal medicine 2004, 140(3):167-174.
5. Hanson RL, Imperatore G, Bennett PH, Knowler WC. Components of the "metabolic syndrome" and incidence of type 2 diabetes. Diabetes 2002, 51(10):3120-3127. 10.2337/diabetes.51.10.3120, 12351457.
6. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. Jama 2002, 287(3):356-359. 10.1001/jama.287.3.356, 11790215.
7. Prevalence of the metabolic syndrome in populations of Asian origin. Comparison of the IDF definition with the NCEP definition. Diabetes research and clinical practice 2007, 76(1):57-67. 10.1016/j.diabres.2006.07.020, 17010470.
8. Thomas GN, Ho SY, Janus ED, Lam KS, Hedley AJ, Lam TH. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population. Diabetes research and clinical practice 2005, 67(3):251-257. 10.1016/j.diabres.2004.07.022, 15713358.
9. Cheung BM, Wat NM, Man YB, Tam S, Thomas GN, Leung GM, Cheng CH, Woo J, Janus ED, Lau CP, et al. Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study. Diabetes care 2007, 30(6):1430-1436. 10.2337/dc06-1820, 17337491.
10. Thomas GN, Schooling CM, McGhee SM, Ho SY, Cheung BM, Wat NM, Janus ED, Lam KS, Lam TH. Metabolic syndrome increases all-cause and vascular mortality: the Hong Kong Cardiovascular Risk Factor Study. Clin Endocrinol (Oxf) 2007, 66(5):666-671. 10.1111/j.1365-2265.2007.02798.x, 17381490.
11. Edwards KL, Austin MA, Newman B, Mayer E, Krauss RM, Selby JV. Multivariate analysis of the insulin resistance syndrome in women. Arterioscler Thromb 1994, 14(12):1940-1945.
12. Anderson PJ, Critchley JA, Chan JC, Cockram CS, Lee ZS, Thomas GN, Tomlinson B. Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality. Int J Obes Relat Metab Disord 2001, 25(12):1782-1788. 10.1038/sj.ijo.0801837, 11781758.
13. Chan JC, Cheung JC, Lau EM, Wooa J, Chan AY, Swaminathan R, Cockrama CS. The metabolic syndrome in Hong Kong Chinese. The interrelationships among its components analyzed by structural equation modeling. Diabetes care 1996, 19(9):953-959. 10.2337/diacare.19.9.953, 8875088.
14. Meigs JB, D'Agostino RB, Wilson PW, Cupples LA, Nathan DM, Singer DE. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes 1997, 46(10):1594-1600. 10.2337/diabetes.46.10.1594, 9313755.
15. Leyva F, Godsland IF, Ghatei M, Proudler AJ, Aldis S, Walton C, Bloom S, Stevenson JC. Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arteriosclerosis, thrombosis, and vascular biology 1998, 18(6):928-933.
16. Kekalainen P, Sarlund H, Pyorala K, Laakso M. Hyperinsulinemia cluster predicts the development of type 2 diabetes independently of family history of diabetes. Diabetes care 1999, 22(1):86-92. 10.2337/diacare.22.1.86, 10333908.
17. Lempiainen P, Mykkanen L, Pyorala K, Laakso M, Kuusisto J. Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation 1999, 100(2):123-128.
18. Sakkinen PA, Wahl P, Cushman M, Lewis MR, Tracy RP. Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. American journal of epidemiology 2000, 152(10):897-907. 10.1093/aje/152.10.897, 11092431.
19. Li JK, Ng MC, So WY, Chiu CK, Ozaki R, Tong PC, Cockram CS, Chan JC. Phenotypic and genetic clustering of diabetes and metabolic syndrome in Chinese families with type 2 diabetes mellitus. Diabetes Metab Res Rev 2006, 22(1):46-52. 10.1002/dmrr.577, 16021651.
20. Ng MC, So WY, Cox NJ, Lam VK, Cockram CS, Critchley JA, Bell GI, Chan JC. Genome-wide scan for type 2 diabetes loci in Hong Kong Chinese and confirmation of a susceptibility locus on chromosome 1q21-q25. Diabetes 2004, 53(6):1609-1613. 10.2337/diabetes.53.6.1609, 15161769.
21. Ng MC, So WY, Lam VK, Cockram CS, Bell GI, Cox NJ, Chan JC. Genome-wide scan for metabolic syndrome and related quantitative traits in Hong Kong Chinese and confirmation of a susceptibility locus on chromosome 1q21-q25. Diabetes 2004, 53(10):2676-2683. 10.2337/diabetes.53.10.2676, 15448100.
22. Arya R, Blangero J, Williams K, Almasy L, Dyer TD, Leach RJ, O'Connell P, Stern MP, Duggirala R. Factors of insulin resistance syndrome--related phenotypes are linked to genetic locations on chromosomes 6 and 7 in nondiabetic mexican-americans. Diabetes 2002, 51(3):841-847. 10.2337/diabetes.51.3.841, 11872689.
23. Tang W, Miller MB, Rich SS, North KE, Pankow JS, Borecki IB, Myers RH, Hopkins PN, Leppert M, Arnett DK. Linkage analysis of a composite factor for the multiple metabolic syndrome: the National Heart, Lung, and Blood Institute Family Heart Study. Diabetes 2003, 52(11):2840-2847. 10.2337/diabetes.52.11.2840, 14578304.
24. Ott J, Rabinowitz D. A principal-components approach based on heritability for combining phenotype information. Human heredity 1999, 49(2):106-111. 10.1159/000022854, 10077732.
25. von Wowern F, Bengtsson K, Lindgren CM, Orho-Melander M, Fyhrquist F, Lindblad U, Rastam L, Forsblom C, Kanninen T, Almgren P, et al. A genome wide scan for early onset primary hypertension in Scandinavians. Human molecular genetics 2003, 12(16):2077-2081. 10.1093/hmg/ddg206, 12913078.
26. Liu W, Zhao W, Chase GA. Genome scan meta-analysis for hypertension. Am J Hypertens 2004, 17(12 Pt 1):1100-1106. 10.1016/j.amjhyper.2004.07.014, 15607615.
27. Rich SS, Bowden DW, Haffner SM, Norris JM, Saad MF, Mitchell BD, Rotter JI, Langefeld CD, Hedrick CC, Wagenknecht LE, et al. A genome scan for fasting insulin and fasting glucose identifies a quantitative trait locus on chromosome 17p: the insulin resistance atherosclerosis study (IRAS) family study. Diabetes 2005, 54(1):290-295. 10.2337/diabetes.54.1.290, 15616041.
28. Freedman BI, Rich SS, Sale MM, Heiss G, Djousse L, Pankow JS, Province MA, Rao DC, Lewis CE, Chen YD, et al. Genome-wide scans for heritability of fasting serum insulin and glucose concentrations in hypertensive families. Diabetologia 2005, 48(4):661-668. 10.1007/s00125-005-1679-5, 15747111.
29. Badzioch MD, Igo RP, Gagnon F, Brunzell JD, Krauss RM, Motulsky AG, Wijsman EM, Jarvik GP. Low-density lipoprotein particle size loci in familial combined hyperlipidemia: evidence for multiple loci from a genome scan. Arteriosclerosis, thrombosis, and vascular biology 2004, 24(10):1942-1950. 10.1161/01.ATV.0000143499.09575.93, 15331429.
30. Perusse L, Rice T, Chagnon YC, Despres JP, Lemieux S, Roy S, Lacaille M, Ho-Kim MA, Chagnon M, Province MA, et al. A genome-wide scan for abdominal fat assessed by computed tomography in the Quebec Family Study. Diabetes 2001, 50(3):614-621. 10.2337/diabetes.50.3.614, 11246882.
31. Jacobson P, Rankinen T, Tremblay A, Perusse L, Chagnon YC, Bouchard C. Resting metabolic rate and respiratory quotient: results from a genome-wide scan in the Quebec Family Study. Am J Clin Nutr 2006, 84(6):1527-1533.
32. Palmer LJ, Buxbaum SG, Larkin E, Patel SR, Elston RC, Tishler PV, Redline S. A whole-genome scan for obstructive sleep apnea and obesity. American journal of human genetics 2003, 72(2):340-350. 10.1086/346064, 379227, 12506338.
33. Das SK, Elbein SC. The search for type 2 diabetes susceptibility loci: the chromosome 1q story. Current diabetes reports 2007, 7(2):154-164. 10.1007/s11892-007-0025-3, 17425920.
34. Demenais F, Kanninen T, Lindgren CM, Wiltshire S, Gaget S, Dandrieux C, Almgren P, Sjogren M, Hattersley A, Dina C, et al. A meta-analysis of four European genome screens (GIFT Consortium) shows evidence for a novel region on chromosome 17p11.2-q22 linked to type 2 diabetes. Human molecular genetics 2003, 12(15):1865-1873. 10.1093/hmg/ddg195, 12874106.
35. Arya R, Duggirala R, Almasy L, Rainwater DL, Mahaney MC, Cole S, Dyer TD, Williams K, Leach RJ, Hixson JE, et al. Linkage of high-density lipoprotein-cholesterol concentrations to a locus on chromosome 9p in Mexican Americans. Nature genetics 2002, 30(1):102-105. 10.1038/ng810, 11743583.
36. Kalmyrzaev B, Aldashev A, Khalmatov M, Polupanov A, Jumagulova A, Mamanova L, Wilkins MR, Town M. Genome-wide scan for premature hypertension supports linkage to chromosome 2 in a large Kyrgyz family. Hypertension 2006, 48(5):908-913. 10.1161/01.HYP.0000244107.13957.2b, 17000929.
37. Bell JT, Wallace C, Dobson R, Wiltshire S, Mein C, Pembroke J, Brown M, Clayton D, Samani N, Dominiczak A, et al. Two-dimensional genome-scan identifies novel epistatic loci for essential hypertension. Human molecular genetics 2006, 15(8):1365-1374. 10.1093/hmg/ddl058, 16543358.
38. Gans RO, Donker AJ. Insulin and blood pressure regulation. J Intern Med Suppl 1991, 735:49-64.
39. Guimaraes S, Moura D. Vascular adrenoceptors: an update. Pharmacol Rev 2001, 53(2):319-356.
40. Anand-Srivastava MB. Atrial natriuretic peptide-C receptor and membrane signalling in hypertension. J Hypertens 1997, 15(8):815-826. 10.1097/00004872-199715080-00004, 9280203.
41. Ahlgren U, Pfaff SL, Jessell TM, Edlund T, Edlund H. Independent requirement for ISL1 in formation of pancreatic mesenchyme and islet cells. Nature 1997, 385(6613):257-260. 10.1038/385257a0, 9000074.
42. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006, 444(7121):881-887. 10.1038/nature05488, 17167477.
43. Bosse Y, Despres JP, Chagnon YC, Rice T, Rao DC, Bouchard C, Perusse L, Vohl MC. Quantitative trait locus on 15q for a metabolic syndrome variable derived from factor analysis. Obesity (Silver Spring) 2007, 15(3):544-550. 10.1038/oby.2007.577, 17372302.
44. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, Helgason A, Stefansson H, Emilsson V, Helgadottir A, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nature genetics 2006, 38(3):320-323. 10.1038/ng1732, 16415884.
45. Helgadottir A, Manolescu A, Thorleifsson G, Gretarsdottir S, Jonsdottir H, Thorsteinsdottir U, Samani NJ, Gudmundsson G, Grant SF, Thorgeirsson G, et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nature genetics 2004, 36(3):233-239. 10.1038/ng1311, 14770184.
46. Steinthorsdottir V, Thorleifsson G, Reynisdottir I, Benediktsson R, Jonsdottir T, Walters GB, Styrkarsdottir U, Gretarsdottir S, Emilsson V, Ghosh S, et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nature genetics 2007, 39(6):770-775. 10.1038/ng2043, 17460697.
47. Wang WY, Barratt BJ, Clayton DG, Todd JA. Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet 2005, 6(2):109-118. 10.1038/nrg1522, 15716907.
48. Boehnke M, Cox NJ. Accurate inference of relationships in sib-pair linkage studies. American journal of human genetics 1997, 61(2):423-429. 10.1086/514862, 1715905, 9311748.
49. McPeek MS, Sun L. Statistical tests for detection of misspecified relationships by use of genome-screen data. American journal of human genetics 2000, 66(3):1076-1094. 10.1086/302800, 1288143, 10712219.
50. O'Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. American journal of human genetics 1998, 63(1):259-266. 10.1086/301904, 1377228, 9634505.
51. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlin--rapid analysis of dense genetic maps using sparse gene flow trees. Nature genetics 2002, 30(1):97-101. 10.1038/ng786, 11731797.
52. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. American journal of human genetics 1998, 62(5):1198-1211. 10.1086/301844, 1377101, 9545414.